Form 4 for MRKR Marker Therapeutics, Inc.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-24 · accession 0001209191-22-021395 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-28 | 2022-03-24 | MRKR | Vera Juan | CSO, COO, Dir | A - Grant | $0.00 | +140.8K | 2.71M | +5% | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Vera Juan | CSO, COO, Dir | F - Tax | $0.48 | -33.5K | 2.67M | -1% | -$16.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | A | A | 140,823 | $0.00 | 2,705,310 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. |
| 2 | Common | Common Stock | 2022-03-24 | F | D | 33,465 | $0.48 | 2,671,845 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. |